Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLN1202 in Diabetic Nephropathy
NCT02410499Phase 2Withdrawn
- Sponsor
- Takeda
- Start
- May 2015
- Primary completion
- Nov 2015
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of plozalizumab in diabetic nephropathy (DN), sponsored by Takeda. Planned start May 2015; status: withdrawn.
02
Drugs
plozalizumab
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02410499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02410499.